| MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma Y Zhan, J Guo, W Yang, C Goncalves, T Rzymski, A Dreas, E Żyłkiewicz, ... The Journal of clinical investigation 127 (11), 4179-4192, 2017 | 74 | 2017 |
| Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses F Huang, C Gonçalves, M Bartish, J Rémy-Sarrazin, ME Issa, B Cordeiro, ... The Journal of clinical investigation 131 (8), 2024 | 52 | 2024 |
| Melanoma plasticity: promoter of metastasis and resistance to therapy F Huang, F Santinon, RE Flores González, SV Del Rincón Frontiers in oncology 11, 756001, 2021 | 49 | 2021 |
| Translation of cancer immunotherapy from the bench to the bedside Q Guo, F Huang, C Goncalves, SV Del Rincón, WH Miller Jr Advances in cancer research 143, 1-62, 2019 | 44 | 2019 |
| MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ Q Guo, VZ Li, JN Nichol, F Huang, W Yang, SEJ Preston, Z Talat, ... Cancer research 79 (7), 1646-1657, 2019 | 35 | 2019 |
| The MNK1/2–eIF4E axis supports immune suppression and metastasis in postpartum breast cancer Q Guo, M Bartish, C Gonçalves, F Huang, J Smith-Voudouris, SS Krisna, ... Cancer research 81 (14), 3876-3889, 2021 | 34 | 2021 |
| MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression W Yang, E Khoury, Q Guo, SA Prabhu, A Emond, F Huang, C Gonçalves, ... Oncogene 39 (18), 3650-3665, 2020 | 22 | 2020 |
| Phosphorylation of eIF4E in the stroma drives the production and spatial organisation of collagen type I in the mammary gland SEJ Preston, M Bartish, VR Richard, A Aghigh, C Goncalves, ... Matrix Biology 111, 264-288, 2022 | 13 | 2022 |
| Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance MS Dahabieh, F Huang, C Goncalves, RE Flores González, S Prabhu, ... Autophagy 18 (3), 540-558, 2022 | 13 | 2022 |
| Peroxisome disruption alters lipid metabolism and potentiates antitumor response with MAPK-targeted therapy in melanoma F Huang, F Cai, MS Dahabieh, K Gunawardena, A Talebi, J Dehairs, ... The Journal of Clinical Investigation 133 (20), 2023 | 7 | 2023 |
| Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer SA Prabhu, O Moussa, C Gonçalves, JH LaPierre, H Chou, F Huang, ... Molecular Cancer Therapeutics 22 (2), 192-204, 2023 | 3 | 2023 |
| Optimized protocol for immunophenotyping of melanoma and tumor-bearing skin from mouse SS Krisna, C Goncalves, N Gagnon, F Huang, D Plourde, WH Miller Jr, ... STAR protocols 2 (3), 100627, 2021 | 3 | 2021 |
| Abstract A53: Phosphorylation of eIF4E promotes phenotype switching and MDSC-mediated immunosuppression in melanoma F Huang, C Gonçalves, Q Guo, J Rémy-Sarrazin, A Emond, W Yang, ... Cancer Immunology Research 8 (3_Supplement), A53-A53, 2020 | 1 | 2020 |
| Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis SEJ Preston, MS Dahabieh, RE Flores González, C Gonçalves, ... Science Advances 10 (37), eadi7673, 2024 | | 2024 |
| MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma (vol 127, pg 4179, 2017) Y Zhan, J Guo, W Yang, C Goncalves, T Rzymski, A Dreas, E Zylkiewicz, ... JOURNAL OF CLINICAL INVESTIGATION 134 (8), 2024 | | 2024 |
| MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma Y Zhan, J Guo, W Yang, C Goncalves, T Rzymski, A Dreas, E Żyłkiewicz, ... Journal of Clinical Investigation 134 (8), e181338, 2024 | | 2024 |
| Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ Q Guo, VZ Li, JN Nichol, F Huang, W Yang, SEJ Preston, Z Talat, ... Cancer Research 84 (8), 1373-1373, 2024 | | 2024 |
| Tunable PhenoCycler imaging of the murine pre-clinical tumour microenvironments MJ Abraham, C Goncalves, P McCallum, V Gupta, SEJ Preston, F Huang, ... Cell & Bioscience 14 (1), 19, 2024 | | 2024 |
| Disrupting peroxisomes alters lipid metabolism in melanoma and uncovers a novel therapeutic vulnerability in combination with MAPK-targeted therapies F Huang, F Cai, MS Dahabieh, K Gunawardena, A Talebi, J Dehairs, ... bioRxiv, 2022.10. 25.513718, 2022 | | 2022 |
| Exploring Novel Strategies to Sensitize Melanoma to Immunotherapy and Targeted Therapies F Huang McGill University (Canada), 2022 | | 2022 |
